Mankind Pharma Limited (MANKIND.NS)
INR 2845.85
(1.42%)
INR 2845.85
(1.42%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 325.81 Million INR | 40.76% |
| 2022 | 231.46 Million INR | -55.64% |
| 2021 | 521.84 Million INR | -16.08% |
| 2020 | 621.81 Million INR | 16.96% |
| 2019 | 531.66 Million INR | 111.72% |
| 2018 | 251.11 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 288 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 325.81 Million INR | 0.0% |
| 2023 FY | 325.81 Million INR | 40.76% |
| 2022 Q4 | 231.46 Million INR | -36.77% |
| 2022 FY | 231.46 Million INR | -55.64% |
| 2022 Q3 | 366.06 Million INR | 0.0% |
| 2021 Q4 | 521.84 Million INR | 0.0% |
| 2021 FY | 521.84 Million INR | -16.08% |
| 2020 FY | 621.81 Million INR | 16.96% |
| 2019 FY | 531.66 Million INR | 111.72% |
| 2018 FY | 251.11 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 265.79 Million INR | -22.58% |
| Ind-Swift Limited | 10.09 Billion INR | 96.773% |
| Bajaj HealthCare Limited | 650.34 Million INR | 49.901% |
| Sakar Healthcare Limited | 549.55 Million INR | 40.712% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 98.474% |
| Innova Captab Limited | 2.1 Billion INR | 84.523% |
| Divi's Laboratories Limited | 20 Million INR | -1529.075% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -1070.481% |
| Morepen Laboratories Limited | 33.64 Million INR | -868.534% |
| Sequent Scientific Limited | 1.42 Billion INR | 77.171% |
| Wanbury Limited | 820 Million INR | 60.266% |
| Laurus Labs Limited | 7.98 Billion INR | 95.918% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 76.779% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -120.727% |
| Alembic Limited | 73.9 Million INR | -340.886% |
| Hikal Limited | 4.22 Billion INR | 92.295% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 48.185% |
| Neuland Laboratories Limited | 449.2 Million INR | 27.469% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -37.824% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 78.521% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Themis Medicare Limited | 267.74 Million INR | -21.691% |
| RPG Life Sciences Limited | -30.3 Million INR | 1175.297% |
| Zydus Lifesciences Limited | 251 Million INR | -29.807% |
| Lupin Limited | 1.55 Billion INR | 79.018% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -2232.582% |
| Wockhardt Limited | 8.91 Billion INR | 96.343% |
| Vaishali Pharma Limited | 35.98 Million INR | -805.469% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -81353.75% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -331.143% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 98.971% |
| FDC Limited | 2.46 Million INR | -13112.287% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 94.561% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 95.022% |
| Venus Remedies Limited | 386.8 Million INR | 15.767% |
| ZIM Laboratories Limited | 356 Million INR | 8.48% |
| Bliss GVS Pharma Limited | 355.92 Million INR | 8.459% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -3441.467% |
| Shilpa Medicare Limited | 5.6 Billion INR | 94.184% |
| Albert David Limited | 6.01 Million INR | -5315.808% |
| Ajanta Pharma Limited | 235.2 Million INR | -38.527% |
| Hester Biosciences Limited | 1.81 Billion INR | 82.076% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -53.429% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 72.257% |
| Gufic Biosciences Limited | 1.53 Billion INR | 78.838% |
| Windlas Biotech Limited | 20.18 Million INR | -1514.544% |
| Procter & Gamble Health Limited | 68.8 Million INR | -373.568% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -910.474% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -143.981% |
| Granules India Limited | 689.71 Million INR | 52.761% |
| Aarti Drugs Limited | 2.75 Billion INR | 88.166% |
| Bal Pharma Limited | 363.82 Million INR | 10.447% |
| Alkem Laboratories Limited | 400 Million INR | 18.546% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -2349.737% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Medicamen Biotech Limited | 12.55 Million INR | -2495.102% |
| Unichem Laboratories Limited | 382.22 Million INR | 14.757% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -202.994% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Valiant Laboratories Limited | 750.89 Million INR | 56.61% |
| Orchid Pharma Limited | 1.2 Billion INR | 72.946% |
| Medico Remedies Limited | 8.67 Million INR | -3657.092% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -191.881% |
| Ipca Laboratories Limited | 5.8 Billion INR | 94.386% |
| Brooks Laboratories Limited | 3.56 Million INR | -9039.271% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 26828.056% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.939% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 97.969% |
| NATCO Pharma Limited | 53 Million INR | -514.745% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 82.244% |
| Strides Pharma Science Limited | 6.71 Billion INR | 95.148% |
| Indoco Remedies Limited | 3.51 Billion INR | 90.737% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -205.643% |